Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Blood ; 82(9): 2684-92, 1993 Nov 01.
Article in English | MEDLINE | ID: mdl-8219221

ABSTRACT

Normal human plasma contains procoagulant albumin (PC-Al), an anionic form of albumin that induces tissue factor (TF) activity in human umbilical vein endothelial cells (HUVEC) and monocytes. In this study, we investigated both the interactions between HUVEC and PC-Al and the mechanism by which PC-Al induces TF activity. Binding of PC-Al to HUVEC was specific and reversible. Further studies indicated that membrane-bound PC-Al was not internalized by HUVEC. A potential receptor on HUVEC was suggested by studies in which the capacity of a variety of reagents to inhibit the activity of PC-Al was quantitated. Induction of TF activity by PC-Al was antagonized by dextran sulfate, heparin, fucoidan, and concanavalin A but not by ovalbumin, polyglutamic acid, or polyvinyl sulfate. This competition profile bears similarities to those reported for scavenger receptors that have been identified on both HUVEC and monocytes. Involvement of protein kinase C (PKC) in the PC-Al-induced enhancement of TF activity was suggested by experiments in which staurosporine, an inhibitor of PKC, suppressed the activity of PC-Al. The induction of TF activity by PC-Al was further characterized by using a quantitative polymerase chain reaction assay. Increased TF mRNA was first seen after 1 hour of incubation with PC-Al. Maximal observed expression occurred at 2 hours, but at 5 hours, expression had significantly decreased. Monocytes could also be induced to express TF mRNA after a 2-hour incubation with PC-Al. These results suggest that the functionally relevant binding of PC-Al to HUVEC may be mediated through interactions with a membrane constituent that has some of the properties of a scavenger receptor and that this interaction augments TF activity by enhancing transcription of TF mRNA, at least in part, by a mechanism that is dependent on activation of PKC.


Subject(s)
Blood Coagulation Factors/pharmacology , Endothelium, Vascular/drug effects , Serum Albumin/pharmacology , Thromboplastin/biosynthesis , Base Sequence , Cells, Cultured , Endothelium, Vascular/metabolism , Humans , Molecular Sequence Data , RNA, Messenger/analysis , Serum Albumin/metabolism , Thromboplastin/genetics
2.
Blood ; 79(11): 2888-95, 1992 Jun 01.
Article in English | MEDLINE | ID: mdl-1586736

ABSTRACT

Molecules that induce tissue factor expression by responsive cells such as endothelial cells and monocytes may be important in the regulation of hemostasis and, perhaps, in mediating certain hemostatic disorders. A constituent of normal human plasma capable of inducing tissue factor activity in human endothelial cells and monocytes has been isolated and identified as a derivative of, or modification associated with albumin. Procoagulant albumin caused a concentration-dependent induction of tissue factor expression by human endothelial cells, but bovine endothelial cells were unresponsive. The dose-response curve developed a plateau phase, indicating that the capacity of endothelial cells to respond to the stimulus was finite. The maximum response induced by the procoagulant albumin was similar to that observed for maximally effective concentrations of endotoxin, interleukin-1, and tumor necrosis factor. Time-course studies showed that procoagulant albumin produced peak activity in 4 to 6 hours. Identification of a procoagulant form of albumin in normal human plasma suggests a potential role for this constituent in regulation of hemostasis.


Subject(s)
Barium Compounds , Chlorides , Endothelium, Vascular/metabolism , Monocytes/metabolism , Serum Albumin/pharmacology , Thromboplastin/biosynthesis , Barium/pharmacology , Cells, Cultured , Dose-Response Relationship, Drug , Electrophoresis, Polyacrylamide Gel , Endothelium, Vascular/drug effects , Endotoxins/pharmacology , Humans , Hydrogen-Ion Concentration , Immunosorbent Techniques , Interleukin-1/pharmacology , Monocytes/drug effects , Serum Albumin/administration & dosage , Serum Albumin/isolation & purification , Tumor Necrosis Factor-alpha/pharmacology , Umbilical Veins
SELECTION OF CITATIONS
SEARCH DETAIL
...